The journal of nutrition, health & aging

, Volume 16, Issue 2, pp 148–154 | Cite as

Pharmacological interventions for geriatric cachexia: A narrative review of the literature

  • A. Yaxley
  • Michelle D. MillerEmail author
  • R. J. Fraser
  • L. Cobiac
Pharmacological Interventions for Geriatric Cachexia



The objective of this review was to investigate the range of pharmacological interventions that have been studied for treatment of geriatric cachexia, and to evaluate their effect on selected clinical outcomes in this population.


Databases including Medline and Cochrane Central Register of Controlled Trials were searched up to March 2010 with search terms including “cache*”, “intervention”, “megestrol acetate” and “cytokine inhibitors”. Studies investigating subjects with mean age <60y or disease-related cachexia were excluded. Outcomes assessed were weight or BMI, body composition, appetite and laboratory parameters indicative of cachexia.


Fifteen publications met the selection criteria, reporting on ten studies. Seven studies investigated use of megestrol acetate (MA): two randomised controlled trials, one case control study, two pre-test/post-test studies and two retrospective chart reviews. Weight/BMI was common amongst outcomes and these studies showed an improvement in weight compared with baseline. MA studies which investigated body composition, appetite and/or laboratory parameters provided some evidence for improvement in these outcomes. Three randomised controlled trials investigated the use of other interventions: ghrelin, growth hormone and vitamin supplementations. All demonstrated a significant increase in lean body mass. The only other outcome of interest in these three trials was weight in one study with a significant increase demonstrated.


Little investigation has been conducted in this population and the diagnosis of cachexia is problematic however these trials provide preliminary evidence for beneficial outcomes in older adults likely to have cachexia. Further high quality adequately powered prospective studies are necessary to provide effective treatment for geriatric cachexia.

Key words

Geriatrics cachexia therapeutics review treatment outcome nutrition 


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.


  1. 1.
    Watterson C, Fraser A, Banks M, Isenring E, Miller M, Silvester C, Heovenaars R, Bauer J, Vivanti A, and Ferguson M (2009) Evidence based practice guidelines for the nutritional management of malnutrition in adult patients across the continuum of care. Nutr Diet 66:S1–S34.CrossRefGoogle Scholar
  2. 2.
    Alibhai SMH, Greenwood C, and Payette H (2005) An approach to the management of unintentional weight loss in elderly people. Can Med Assoc J 172:773–780.CrossRefGoogle Scholar
  3. 3.
    Thomas DR (2005) Weight loss in older adults. Rev Endocr Metab Dis 6:129–136.CrossRefGoogle Scholar
  4. 4.
    Chapman IM, MacIntosh CG, Morley JE, and Horowitz M (2002) The anorexia of ageing. Biogerontology 3:67–71.PubMedCrossRefGoogle Scholar
  5. 5.
    Finestone H, Greene-Finestone L, Wilson E, and Teasell R (1996) Prolonged length of stay and reduced functional improvement rate in malnourished stroke rehabilitation patients. Arch Phys Med Rehab 77:340–345.CrossRefGoogle Scholar
  6. 6.
    Blackburn GL, Bistrian BR, Maini BS, Schlamm HT, and Smith MF (1977) Nutritional and metabolic assessment of the hospitalised patient. JPEN 1:11–22.CrossRefGoogle Scholar
  7. 7.
    Wallace JI, Schwartz RS, LaCroix AZ, Uhlmann RF, and Pearlman RA (1995) Involuntary weight loss in older outpatients: incidence and clinical significance. [see comment]. J Am Geriatr Soc 43:329–337.PubMedGoogle Scholar
  8. 8.
    Tully CL and Snowdon DA (1995) Weight change and physical function in older women: findings from the Nun Study. J Am Geriatr Soc 43:1394–1397.PubMedGoogle Scholar
  9. 9.
    Milne AC, Potter J, Vivanti A, and Avenell A (2009) Protein and energy supplementation in elderly people at risk from malnutrition.[update of Cochrane Database Syst Rev. 2005;(2):CD003288; PMID: 15846655]. Cochrane DB Syst Rev:CD003288.Google Scholar
  10. 10.
    Wallace JI and Schwartz RS (2002) Epidemiology of weight loss in humans with special reference to wasting in the elderly. Int J Cardiol 85:15–21.PubMedCrossRefGoogle Scholar
  11. 11.
    Thomas DR (2002) Distinguishing starvation from cachexia. Clin Ger Med 18:883–891.CrossRefGoogle Scholar
  12. 12.
    Kotler DP (2000) Cachexia. Ann Intern Med 133:622–634.PubMedGoogle Scholar
  13. 13.
    Morley JE and Thomas DR (2008) Cachexia: new advances in the management of wasting diseases. J Am Med Dir Assoc 9:205–210.PubMedCrossRefGoogle Scholar
  14. 14.
    Thomas DR (2007) Loss of skeletal muscle mass in aging: examining the relationship of starvation, sarcopenia and cachexia. Clin Nutr 26:389–399.PubMedCrossRefGoogle Scholar
  15. 15.
    Yeh S-S and Schuster MW (1999) Geriatric cachexia: the role of cytokines. Am J Clin Nutr 70:183–197.PubMedGoogle Scholar
  16. 16.
    Yeh S, Wu SY, Levine DM, Parker TS, Olson JS, Stevens MR, and Schuster MW (2000) Quality of life and stimulation of weight gain after treatment with megestrol acetate: correlation between cytokine levels and nutritional status, appetite in geriatric patients with wasting syndrome. J Nutr Health Aging 4:246–251.PubMedGoogle Scholar
  17. 17.
    Yeh SS, Wu SY, Lee TP, Olson JS, Stevens MR, Dixon T, Porcelli RJ, and Schuster MW (2000) Improvement in quality-of-life measures and stimulation of weight gain after treatment with megestrol acetate oral suspension in geriatric cachexia: results of a double-blind, placebo-controlled study.[see comment]. J Am Geriatr Soc 48:485–492.PubMedGoogle Scholar
  18. 18.
    Yeh S-S, Hafner A, Chang C-K, Levine DM, Parker TS, and Schuster MW (2004) Risk Factors Relating Blood Markers of Inflammation and Nutritional Status to Survival in Cachectic Geriatric Patients in a Randomized Clinical Trial. J Am Geriatr Soc 52:1708–1712.PubMedCrossRefGoogle Scholar
  19. 19.
    Yeh SS, Wu SY, Levine DM, Parker TS, Olson JS, Stevens MR, and Schuster MW (2001) The correlation of cytokine levels with body weight after megestrol acetate treatment in geriatric patients. J Gerontol A-Biol 56:M48–M54.CrossRefGoogle Scholar
  20. 20.
    Yeh S-S, Lovitt S, and Schuster MW (2009) Usage of megestrol acetate in the treatment of anorexia-cachexia syndrome in the elderly. J Nutr Health Aging 13:448–454.PubMedCrossRefGoogle Scholar
  21. 21.
    Karcic E, Philpot C, and Morley J (2000) Megestrol acetate treatment in older persons in long-term care facilities. J Invest Med 48:261.Google Scholar
  22. 22.
    Karcic E, Philpot C, and Morley JE (2002) Treating malnutrition with megestrol acetate: literature review and review of our experience. J Nutr Health Aging 6:191–200.PubMedGoogle Scholar
  23. 23.
    Bodenner D, Spencer T, Riggs AT, Redman C, Strunk B, and Hughes T (2007) A retrospective study of the association between megestrol acetate administration and mortality among nursing home residents with clinically significant weight loss. Am J Geriatr Pharmacother 5:137–146.PubMedCrossRefGoogle Scholar
  24. 24.
    Reuben DB, Hirsch SH, Zhou K, and Greendale GA (2005) The Effects of Megestrol Acetate Suspension for Elderly Patients with Reduced Appetite After Hospitalization: A Phase II Randomized Clinical Trial. J Am Geriatr Soc 53:970–975.PubMedCrossRefGoogle Scholar
  25. 25.
    Castle S, Nguyen C, Joaquin A, Coyne B, Heuston C, Chan A, Percy L, and Ohmen J (1995) Megestrol acetate suspension therapy in the treatment of geriatric anorexia/cachexia in nursing home patients. J Am Geriatr Soc 43:835–836.PubMedGoogle Scholar
  26. 26.
    Raney MS, Anding R, Fay V, and Polk G (2000) A pilot study to assess the use of megesterol acetate to promote weight gain in frail elderly persons residing in long term care. J Am Med Dir Assoc 1:154–158.PubMedGoogle Scholar
  27. 27.
    Jackobs MK (1999) Megestrol Acetate: A Medical Nutrition Therapy Tool to Effect Positive Weight Outcomes in the Elderly. J Am Diet Assoc 99:A119–A119.CrossRefGoogle Scholar
  28. 28.
    Akamizu T, Iwakura H, Ariyasu H, Murayama T, Sumi E, Teramukai S, Goto K, Ohnishi E, Akiyama H, Kawanabe K, Nankaku M, Ichihashi N, Tsuboyama T, Tamai K, Kataoka M, Nakamura T, Kangawa K, and Osteoarthritis-Total Hip Replacement Clinical Study T (2008) Effects of ghrelin treatment on patients undergoing total hip replacement for osteoarthritis: different outcomes from studies in patients with cardiac and pulmonary cachexia. J Am Geriatr Soc 56:2363–2365.PubMedCrossRefGoogle Scholar
  29. 29.
    Burns A, Marsh A, and Bender DA (1989) A trial of vitamin supplementation in senile dementia. Int J Geriatr Psych 4:333–338.CrossRefGoogle Scholar
  30. 30.
    Weissberger AJ, Anastasiadis AD, Sturgess I, Martin FC, Smith MA, and Sonksen PH (2003) Recombinant human growth hormone treatment in elderly patients undergoing elective total hip replacement. Clin Endocrinol 58:99–107.CrossRefGoogle Scholar
  31. 31.
    National Health and Medical Research Council (2008) NHMRC additional levels of evidence and grades for recommendations for developers of guidelines — Stage 2 Consultation paper. %202%20Consultation% 20Levels%20and%20Grades.pdf.
  32. 32.
    Oster MH, Enders SR, Samuels SJ, Cone LA, Hooton TM, Browder HP, and Flynn NM (1994) Megestrol acetate in patients with AIDS and cachexia. [see comment]. Ann Intern Med 121:400–408.PubMedGoogle Scholar
  33. 33.
    Lambert CP, Sullivan DH, Freeling SA, Lindquist DM, and Evans WJ (2002) Effects of testosterone replacement and/or resistance exercise on the composition of megestrol acetate stimulated weight gain in elderly men: a randomized controlled trial. J Clin Endocr Metab 87:2100–2106.PubMedCrossRefGoogle Scholar
  34. 34.
    Kamiji MM and Inui A (2008) The role of ghrelin and ghrelin analogues in wasting disease. Curr Opin Clin Nutr 11:443–451.CrossRefGoogle Scholar
  35. 35.
    Nass R, Pezzoli SS, Oliveri MC, Patrie JT, Harrell FE, Jr., Clasey JL, Heymsfield SB, Bach MA, Vance ML, and Thorner MO (2008) Effects of an oral ghrelin mimetic on body composition and clinical outcomes in healthy older adults: a randomized trial.[Summary for patients in Ann Intern Med. 2008 Nov 4;149(9):I–36; PMID: 18981483]. Ann Intern Med 149:601–611.Google Scholar
  36. 36.
    Pascual López A, Roqué i Figuls M, Urrútia Cuchi G, Graciela Berenstein E, Almenar Pasies B, Balcells Alegre M, and Herdman M (2004) Systematic review of megestrol acetate in the treatment of anorexia-cachexia syndrome. J Pain Symptom Manag 27:360–369.CrossRefGoogle Scholar

Copyright information

© Serdi and Springer Verlag France 2012

Authors and Affiliations

  • A. Yaxley
  • Michelle D. Miller
    • 1
    Email author
  • R. J. Fraser
  • L. Cobiac
  1. 1.Nutrition and Dietetics, Clinical and Molecular MedicineFlinders UniversityAdelaideAustralia

Personalised recommendations